Clinical Trial Update: A Phase I Dose Finding Study of APO010 in Patients With Solid Tumors [Phase 1]

View source ↗

Summary

This clinical trial entry notes the completion of a Phase I dose-finding study of APO010 in patients with solid tumors, sponsored by Valerio Therapeutics.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Drugs mentioned

• APO010

Snippet

Sponsor: Valerio Therapeutics | Conditions: Cancer | Phase 1 | Status: COMPLETED